Experior 10 Experior 50 is a drug owned by ELANCO US INC. It is protected by 3 US drug patents filed from 2025 to 2037. Out of these, 2 patents are active and 1 patent has expired. Details of Experior 10 Experior 50’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US6730792 | 20 Apr, 2025 | Expired |
Exclusivity Information
Experior 10 Experior 50 holds 1 exclusivity out of which 1 has expired. Details of Experior 10 Experior 50's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCE | Nov 06, 2023 |
About Experior 10 Experior 50
Experior 10 Experior 50 is a drug
owned by ELANCO US INC.
Experior 10 Experior 50 uses
Lubabegron as the active
ingredient.
Active Ingredient:
Experior 10 Experior 50 uses
Lubabegron as the active ingredient.
Check out other Drugs and Companies using
Lubabegron ingredient.